These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25565868)

  • 1. Decreased expression of APAF-1 and increased expression of cathepsin B in invasive pituitary adenoma.
    Tanase C; Albulescu R; Codrici E; Calenic B; Popescu ID; Mihai S; Necula L; Cruceru ML; Hinescu ME
    Onco Targets Ther; 2015; 8():81-90. PubMed ID: 25565868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in immunoexpression of p53, Ki-67, Ets-1, APAF-1 and PTEN in serrated and conventional colon adenomas.
    Pap Z; Ilyés IÁ; Mocan SL; Dénes L; Muică Nagy-Bota MC; Pávai Z; Szántó A
    Rom J Morphol Embryol; 2015; 56(4):1389-96. PubMed ID: 26743285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki-67 labeling index and expression of p53 are non-predictive for invasiveness and tumor size in functional and nonfunctional pituitary adenomas.
    Grimm F; Maurus R; Beschorner R; Naros G; Stanojevic M; Gugel I; Giese S; Bier G; Bender B; Honegger J
    Acta Neurochir (Wien); 2019 Jun; 161(6):1149-1156. PubMed ID: 31037500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
    Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
    Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleostemin and ASPP2 expression is correlated with pituitary adenoma proliferation.
    Ma L; Chen ZM; Li XY; Wang XJ; Shou JX; Fu XD
    Oncol Lett; 2013 Nov; 6(5):1313-1318. PubMed ID: 24179515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
    Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-functioning pituitary adenomas: clinical features and immunohistochemistry].
    Ferreira JE; de Mello PA; de Magalhães AV; Botelho CH; Naves LA; Nosé V; Schmitt F
    Arq Neuropsiquiatr; 2005 Dec; 63(4):1070-8. PubMed ID: 16400431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of the retinoblastoma tumor suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis.
    Guo Z; Yikang S; Yoshida H; Mak TW; Zacksenhaus E
    Cancer Res; 2001 Dec; 61(23):8395-400. PubMed ID: 11731416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation markers in different types of clinically non-secreting pituitary adenomas.
    Schreiber S; Saeger W; Lüdecke DK
    Pituitary; 1999 May; 1(3-4):213-20. PubMed ID: 11081200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic markers of invasive pituitary adenomas involving the sphenoid sinus.
    Gandour-Edwards R; Kapadia SB; Janecka IP; Martinez AJ; Barnes L
    Mod Pathol; 1995 Feb; 8(2):160-4. PubMed ID: 7777477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiregional sampling reveals a homogenous distribution of Ki-67 proliferation rate in pituitary adenomas.
    Wolfsberger S; Kitz K; Wunderer J; Czech T; Boecher-Schwarz HG; Hainfellner JA; Knosp E
    Acta Neurochir (Wien); 2004 Dec; 146(12):1323-7; discussion 1327-8. PubMed ID: 15480830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation Markers and EGF in ACTH-Secreting Adenomas and Carcinomas of the Pituitary.
    Lubke D; Saeger W; Ludecke DK
    Endocr Pathol; 1995; 6(1):45-55. PubMed ID: 12114689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53.
    Kasuki Jomori de Pinho L; Vieira Neto L; Armondi Wildemberg LE; Gasparetto EL; Marcondes J; de Almeida Nunes B; Takiya CM; Gadelha MR
    Neuroendocrinology; 2011; 94(1):39-48. PubMed ID: 21178332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are nonfunctioning pituitary adenomas extending into the cavernous sinus aggressive and/or invasive?
    Yokoyama S; Hirano H; Moroki K; Goto M; Imamura S; Kuratsu JI
    Neurosurgery; 2001 Oct; 49(4):857-62; discussion 862-3. PubMed ID: 11564246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody.
    Pizarro CB; Oliveira MC; Coutinho LB; Ferreira NP
    Braz J Med Biol Res; 2004 Feb; 37(2):235-43. PubMed ID: 14762579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APAF-1 signaling in human melanoma.
    Anichini A; Mortarini R; Sensi M; Zanon M
    Cancer Lett; 2006 Jul; 238(2):168-79. PubMed ID: 16095810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of APAF-1 in B-CLL results in poor prognosis in the case of concomitant p53 mutation.
    Sturm I; Bosanquet AG; Radetzki S; Hummel M; Dörken B; Daniel PT
    Int J Cancer; 2006 May; 118(9):2329-36. PubMed ID: 16331630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W; Lüdecke B; Lüdecke DK
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
    Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW
    Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between SPARC (Osteonectin) expression with immunophenotypical and invasion characteristics of pituitary adenomas.
    Onoz M; Basaran R; Gucluer B; Isik N; Kaner T; Sav A; Elmaci I
    APMIS; 2015 Mar; 123(3):199-204. PubMed ID: 25556322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.